{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T13:00:32Z","timestamp":1788094832570,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00535-019-01656-9","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T11:03:58Z","timestamp":1588071838000},"page":"533-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis"],"prefix":"10.1007","volume":"55","author":[{"given":"R\u00e9my","family":"Schwarzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijel","family":"Kivaranovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Hametner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hametner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Paternostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Schneeweiss-Friedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Schoefl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-3549","authenticated-orcid":false,"given":"Andreas","family":"Maieron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"1656_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000317248","volume":"16","author":"WA Zato\u0144ski","year":"2010","unstructured":"Zato\u0144ski WA, Sulkowska U, Ma\u0144czuk M, et al. Liver cirrhosis mortality in Europe, with special attention to central and eastern Europe. Eur Addict Res. 2010;16:193\u2013201.","journal-title":"Eur Addict Res"},{"key":"1656_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Faculty BVI. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u201352.","journal-title":"J Hepatol"},{"key":"1656_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1586\/egh.12.83","volume":"7","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti A, Seijo S, Reverter E, et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141\u201355.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1656_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","volume":"133","author":"C Ripoll","year":"2007","unstructured":"Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481\u20138.","journal-title":"Gastroenterology"},{"key":"1656_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D'Amico","year":"2018","unstructured":"D'Amico G, Morabito A, D'Amico M, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563\u201376.","journal-title":"J Hepatol"},{"key":"1656_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00508-017-1262-3","volume":"129","author":"T Reiberger","year":"2017","unstructured":"Reiberger T, P\u00fcsp\u00f6k A, Schoder M, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr. 2017;129:135\u201358.","journal-title":"Wien Klin Wochenschr"},{"key":"1656_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310\u201335.","journal-title":"Hepatology"},{"key":"1656_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","volume":"7","author":"AA Qamar","year":"2009","unstructured":"Qamar AA, Grace ND, Groszmann RJ, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689\u201395.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1656_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","volume":"144","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti A, Seijo S, Arena U, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013;144:102\u201311.","journal-title":"Gastroenterology"},{"key":"1656_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0168-8278(99)80288-8","volume":"31","author":"C Pilette","year":"1999","unstructured":"Pilette C, Oberti F, Aub\u00e9 C, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol. 1999;31:867\u201373.","journal-title":"J Hepatol"},{"key":"1656_CR11","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1111\/j.1572-0241.1999.1539_a.x","volume":"94","author":"N Chalasani","year":"1999","unstructured":"Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999;94:3285\u201391.","journal-title":"Am J Gastroenterol"},{"key":"1656_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/jhep.2001.21410","volume":"33","author":"F Schepis","year":"2001","unstructured":"Schepis F, Camm\u00e0 C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33:333\u20138.","journal-title":"Hepatology"},{"issue":"161","key":"1656_CR13","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/archinte.161.21.2564","volume":"26","author":"A Zaman","year":"2001","unstructured":"Zaman A, Becker T, Lapidus J, et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;26(161):2564\u201370.","journal-title":"Arch Intern Med"},{"key":"1656_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00004836-200201000-00016","volume":"34","author":"R Madhotra","year":"2002","unstructured":"Madhotra R, Mulcahy HE, Willner I, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34:81\u20135.","journal-title":"J Clin Gastroenterol"},{"key":"1656_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1590-8658(03)00219-6","volume":"35","author":"KC Thomopoulos","year":"2003","unstructured":"Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, et al. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis. 2003;35:473\u20138.","journal-title":"Dig Liver Dis"},{"key":"1656_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/hep.20029","volume":"39","author":"CO Zein","year":"2004","unstructured":"Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology. 2004;39:204\u201310.","journal-title":"Hepatology"},{"key":"1656_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000\u20137.","journal-title":"J Hepatol"},{"key":"1656_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/apt.14522","volume":"47","author":"M Mandorfer","year":"2018","unstructured":"Mandorfer M, Schwabl P, Paternostro R, et al. Von Willebrand Factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Aliment Pharmacol Ther. 2018;47:980\u20138.","journal-title":"Aliment Pharmacol Ther."},{"key":"1656_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.21231","volume":"44","author":"T Lisman","year":"2006","unstructured":"Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44:53\u201361.","journal-title":"Hepatology"},{"issue":"88","key":"1656_CR20","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","volume":"15","author":"CA Siedlecki","year":"1996","unstructured":"Siedlecki CA, Lestini BJ, Kottke-Marchant KK, et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand Factor. Blood. 1996;15(88):2939\u201350.","journal-title":"Blood"},{"issue":"99","key":"1656_CR21","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1182\/blood-2001-11-0060","volume":"1","author":"M Arya","year":"2002","unstructured":"Arya M, Anvari B, Romo GM, et al. Ultralarge multimers of von Willebrand Factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002;1(99):3971\u20137.","journal-title":"Blood"},{"key":"1656_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/apt.12564","volume":"39","author":"A Maieron","year":"2014","unstructured":"Maieron A, Salzl P, Peck-Radosavljevic M, et al. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2014;39:331\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"1656_CR23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/hep.25806","volume":"56","author":"M Ferlitsch","year":"2012","unstructured":"Ferlitsch M, Reiberger T, Hoke M, et al. von Willebrand Factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Hepatology. 2012;56:1439\u201347.","journal-title":"Hepatology"},{"issue":"11","key":"1656_CR24","doi-asserted-by":"publisher","first-page":"e0149230","DOI":"10.1371\/journal.pone.0149230","volume":"19","author":"S Hametner","year":"2016","unstructured":"Hametner S, Ferlitsch A, Ferlitsch M, et al. The VITRO Score (von Willebrand Factor antigen\/thrombocyte ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test. PLoS ONE. 2016;19(11):e0149230.","journal-title":"PLoS ONE"},{"key":"1656_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00508-012-0190-5","volume":"124","author":"T Reiberger","year":"2012","unstructured":"Reiberger T, Ferlitsch A, Payer BA, et al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography\u2014a large single center experience. Wien Klin Wochenschr. 2012;124:395\u2013402.","journal-title":"Wien Klin Wochenschr"},{"key":"1656_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/liv.12623","volume":"35","author":"P Schwabl","year":"2015","unstructured":"Schwabl P, Bota S, Salzl P, et al. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int. 2015;35:381\u201390.","journal-title":"Liver Int"},{"key":"1656_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217\u201331.","journal-title":"J Hepatol"},{"key":"1656_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/hepr.13253","volume":"49","author":"R Paternostro","year":"2019","unstructured":"Paternostro R, Heinisch BB, Reiberger T, et al. Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis. Hepatol Res. 2019;49:201\u201311.","journal-title":"Hepatol Res"},{"key":"1656_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/hep.30885","volume":"1","author":"M Mandorfer","year":"2019","unstructured":"Mandorfer M, Kozbial K, Schwabl P, et al. Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy. Hepatology. 2019;1:2. https:\/\/doi.org\/10.1002\/hep.30885[Epub ahead of print].","journal-title":"Hepatology"},{"key":"1656_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jgh.14700","volume":"1","author":"G Semmler","year":"2019","unstructured":"Semmler G, Simbrunner B, Scheiner B, et al. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension. J Gastroenterol Hepatol. 2019;1:2. https:\/\/doi.org\/10.1111\/jgh.14700[Epub ahead of print].","journal-title":"J Gastroenterol Hepatol"},{"key":"1656_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/liv.13943","volume":"39","author":"B Scheiner","year":"2019","unstructured":"Scheiner B, Steininger L, Semmler G, et al. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease. Liver Int. 2019;39:127\u201335.","journal-title":"Liver Int"},{"key":"1656_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u201360.","journal-title":"J Hepatol"},{"issue":"446","key":"1656_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94(446):496\u2013509.","journal-title":"JASA"},{"key":"1656_CR34","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254\u201361.","journal-title":"N Engl J Med"},{"key":"1656_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/hep.28264","volume":"63","author":"C Villanueva","year":"2016","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, et al. Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016;63:197\u2013206.","journal-title":"Hepatology"},{"key":"1656_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3851\/IMP1654","volume":"15","author":"S Pramhas","year":"2010","unstructured":"Pramhas S, Homoncik M, Ferenci P, et al. von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4. Antivir Ther. 2010;15:831\u20139.","journal-title":"Antivir Ther"},{"issue":"21","key":"1656_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2036.2004.02305.x","volume":"1","author":"M Homoncik","year":"2005","unstructured":"Homoncik M, Ferlitsch A, Ferenci P, et al. Short- and long-term effects of therapy with interferon-alpha and pegylated interferonapha\/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2005;1(21):49\u201355.","journal-title":"Aliment Pharmacol Ther"},{"key":"1656_CR38","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","volume":"65","author":"M Mandorfer","year":"2016","unstructured":"Mandorfer M, Kozbial K, Schwabl P, et al. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol. 2016;65:692\u20139.","journal-title":"J Hepatol"},{"key":"1656_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","volume":"153","author":"S Lens","year":"2017","unstructured":"Lens S, Alvarado-Tapias E, Mari\u00f1o Z, et al. Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis. Gastroenterology. 2017;153:1273\u201383.","journal-title":"Gastroenterology"},{"key":"1656_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson J, Lemoinne S, Boulanger C, et al. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol. 2017;66:212\u201327.","journal-title":"J Hepatol"},{"key":"1656_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/apt.13844","volume":"45","author":"P Schwabl","year":"2017","unstructured":"Schwabl P, Mandorfer M, Steiner S, et al. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV\/HCV patients with advanced liver disease. Aliment Pharmacol Ther. 2017;45:139\u201349.","journal-title":"Aliment Pharmacol Ther"},{"key":"1656_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.bpg.2003.10.005","volume":"18","author":"G Garcia-Tsao","year":"2004","unstructured":"Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol. 2004;18:353\u201372.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1656_CR43","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","volume":"67","author":"R Carnevale","year":"2017","unstructured":"Carnevale R, Raparelli V, Nocella C, et al. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J Hepatol. 2017;67:950\u20136.","journal-title":"J Hepatol"},{"key":"1656_CR44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.510230613","volume":"23","author":"D Ferro","year":"1996","unstructured":"Ferro D, Quintarelli C, Lattuada A, et al. High plasma levels of von Willebrand Factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology. 1996;23:1377\u201383.","journal-title":"Hepatology"},{"issue":"25","key":"1656_CR45","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.3748\/wjg.v25.i39.5897","volume":"21","author":"B Simbrunner","year":"2019","unstructured":"Simbrunner B, Mandorfer M, Trauner M, et al. Gut-liver axis signaling in portal hypertension. World J Gastroenterol. 2019;21(25):5897\u2013917.","journal-title":"World J Gastroenterol"},{"key":"1656_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/jvh.12706","volume":"24","author":"N Afdhal","year":"2017","unstructured":"Afdhal N, Everson GT, Calleja JL, et al. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension. J Viral Hepat. 2017;24:823\u201331.","journal-title":"J Viral Hepat"},{"key":"1656_CR47","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","volume":"50","author":"C Ripoll","year":"2009","unstructured":"Ripoll C, Groszmann RJ, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50:923\u20138.","journal-title":"J Hepatol"},{"issue":"9","key":"1656_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-230X-9-50","volume":"30","author":"P Jepsen","year":"2009","unstructured":"Jepsen P, Vilstrup H, Ott P, et al. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study. BMC Gastroenterol. 2009;30(9):50.","journal-title":"BMC Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-019-01656-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T01:20:26Z","timestamp":1607649626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-019-01656-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01656-9","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"10 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}